Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study
CAPTURE AMI
1 other identifier
interventional
60
1 country
1
Brief Summary
The CAPTURE AMI trial is an investigator-initiated, single-centre, two-arm, randomised controlled trial. Patients aged ≥ 18 years who present with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) will be enrolled after angiographic evidence of a high thrombus burden (TIMI thrombus grade ≥ 4) and meeting the inclusion criteria laid out in section 9.2 will be 1:1 randomised to receive either standalone PCI (Arm 1) or adjunct sustained mechanical thrombectomy + PCI (Arm 2). The CAPTURE AMI study will enrol specifically patients with: A. Evidence of high thrombus burden on coronary angiography (TIMI thrombus grade ≥ 4) B. Culprit in an artery with a diameter of 3.0 mm or more. The trial is designed to evaluate the efficacy of sustained mechanical thrombectomy versus standalone PCI in patients with a large thrombus burden assessed angiographically, with a pre-stent thrombus burden (%) as the primary imaging endpoint.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jul 2026
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 7, 2026
CompletedStudy Start
First participant enrolled
July 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 8, 2028
July 10, 2026
June 1, 2026
1 year
June 25, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pre stent Thrombus Burden
Pre stent Thrombus Burden (thrombus volume/lumen volume) evaluated by Optical Coherence Tomography
Pre stent implantation (Periprocedural)
Other Outcomes (6)
Clinical Outcomes
In hospital (Pre-discharge), 30 days & 6 months
Efficacy of thrombus burden reduction
Pre stent implantation (Periprocedural)
Efficacy of thrombus burden reduction
Pre stent Implantation (Periprocedural)
- +3 more other outcomes
Study Arms (2)
Standalone PCI
ACTIVE COMPARATORStandalone OCT guided PCI
PCI & Sustained thrombectomy
EXPERIMENTALOCT guided PCI \& Sustained Thrombectomy
Interventions
Sustained thrombectomy with the Indigo® System CAT™ RX aspiration catheter
Optical Coherence Tomography guided Percutaneous Coronary Intervention
Eligibility Criteria
You may qualify if:
- Primary PCI patient with ST elevation myocardial infarction
- Angiographic criteria:
- TIMI 0/1 flow at presentation
- Angiographic thrombus score ≥ 4
- Vessel diameter at site of occlusion ≥ 3.0mm (determined by coronary angiography)
You may not qualify if:
- Female participant who is pregnant or lactating
- Unconscious at presentation
- Late STEMI presentation (symptoms onset to wire time \> 12 h)
- Clinically/haemodynamically unstable patients
- Known diagnosis of severe renal disease (CKD stage 4-5)
- Suspected spontaneous coronary artery dissection
- Previous CABG
- Previous history on STEMI in the same culprit territory
- Known moderate-severe anaemia (Hb \< 9)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oxford Heart Centre - John Radcliffe Hospital
Oxford, Oxfordshire, OX3 9DU, United Kingdom
Related Publications (3)
Kotronias RA, Walsh JL, Andreaggi S, Portolan L, Maino A, Marin F, Chai J, Sobirov I, Sheikh M, Cahill TJ, Lucking AJ, Costello M, Fraile Moreno E, Haridas V, Shaji A, Garcia-Garcia HM, Channon KM, Banning AP, Langrish JP, De Maria GL; OxAMI and RETRIEVE AMI Investigators. Stent-Retriever Thrombectomy in STEMI With Large Thrombus Burden: The RETRIEVE AMI Randomized Trial. JACC Adv. 2025 Jul;4(7):101893. doi: 10.1016/j.jacadv.2025.101893. Epub 2025 Jun 23.
PMID: 40555011BACKGROUNDWalsh JL, Kotronias RA, Banning AP, De Maria GL. Interventional thrombus modification in STEMI. Nat Rev Cardiol. 2024 Jul;21(7):435-436. doi: 10.1038/s41569-024-01020-2. No abstract available.
PMID: 38565957BACKGROUNDKotronias RA, Marin F, Emfietzoglou M, Langrish JP, Lucking AJ, Channon KM, Banning AP, De Maria GL. Rationale and Design of a Randomized Controlled Pilot Trial to Assess Stent Retriever Thrombectomy for Thrombus Burden Reduction in Patients with Acute Myocardial Infarction: The RETRIEVE-AMI Study. Cardiovasc Revasc Med. 2023 Jul;52:75-85. doi: 10.1016/j.carrev.2023.02.012. Epub 2023 Mar 6.
PMID: 36894360BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 7, 2026
Study Start
July 8, 2026
Primary Completion (Estimated)
July 8, 2027
Study Completion (Estimated)
January 8, 2028
Last Updated
July 10, 2026
Record last verified: 2026-06